Stimulant treatment of frontotemporal dementia in 8 patients.
Huey
Edward D
ED
Garcia
Charisse
C
Wassermann
Eric M
EM
Tierney
Michael C
MC
Grafman
Jordan
J
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D018592:Cross-Over Studies; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use*; D003987:Dibenzothiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D009483:Neuropsychological Tests; D000069348:Quetiapine Fumarate
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D003913:Dextroamphetamine